ARWR
Arrowhead Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
9.00 / 10
Outperform
Sentiment is very positive (9.0) and fund‑flow score 7.82, with overall inflow ratios above 0.5. Medium and large investors show slight outflows. Analysts issue three Strong‑Buy calls (100% consensus); one analyst has 0% historic win‑rate, another 80%.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-22
InstitutionB. Riley Securities
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of ARWR?
- ARWR holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 9.00/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
